VBIO

White House Announces Research Priorities for Fiscal Year 2021

In an August 30, 2019 memo from the White House Office of Science and Technology Policy (OSTP) and Office of Management and Budget (OMB), federal agencies have been directed to prioritize national security, industrial leadership, energy and environmental leadership, health and bioeconomic innovation, and space exploration and commercialization in their fiscal year (FY) 2021 budget request for research and development (R&D).
 
The Administration’s memo on R&D budget priorities for FY 2021 provides guidance for a national strategy “to advance bold, transformational leaps in [science and technology], build a diverse workforce of the future, solve previously intractable grand challenges, and ensure America remains the global S&T leader for generations to come.”
 
In regards to public health, the memo directs agencies to prioritize research on the opioid crisis, infectious diseases, anti-microbial resistance, gene therapy, neuroscience, and HIV/ AIDS, among others.  The Administration also stresses prioritizing the bioeconomy, defined in the memo as “the infrastructure, innovation, products, technology, and data derived from biologically-related processes and science that drive economic growth, promote health, and increase public benefit.”  To enable bioeconomic opportunities, agencies have been directed to focus on areas such as biotechnology, scientific collections, biosecurity, omics, and data analytics, and prioritize “evidence-based standards and research to rapidly establish microorganism, plant, and animal safety and efficacy for products developed using gene editing.”

Read more

(AIBS)